Efficacy, immunogenicity, and safety of the 9-valent human papillomavirus vaccine in males aged 16-26 years in Japan: a randomised, double-blind, placebo-controlled trial. (linkinghub.elsevier.com)

Authors: Hisamoto K … Sawata M Journal: Lancet Infectious Diseases Published: 2026-08-03 DOI: https://doi.org/10.1016/S1473-3099(26)00291-4